

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | barbed-end actin filament capping (GO:0051016) | 4.16218367 |
| 2 | negative regulation of protein localization to cell surface (GO:2000009) | 4.00699997 |
| 3 | positive regulation of osteoblast proliferation (GO:0033690) | 3.85641993 |
| 4 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.69877982 |
| 5 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.60377982 |
| 6 | response to thyroid hormone (GO:0097066) | 3.51377356 |
| 7 | glutamate secretion (GO:0014047) | 3.51186195 |
| 8 | synaptic vesicle maturation (GO:0016188) | 3.48906034 |
| 9 | protein neddylation (GO:0045116) | 3.47363440 |
| 10 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.47115547 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.46604369 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 3.46604369 |
| 13 | platelet aggregation (GO:0070527) | 3.43662445 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.42949665 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 3.40545474 |
| 16 | positive regulation of receptor recycling (GO:0001921) | 3.33086896 |
| 17 | regulation of receptor recycling (GO:0001919) | 3.24357996 |
| 18 | L-phenylalanine catabolic process (GO:0006559) | 3.22404731 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.22404731 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 3.21565635 |
| 21 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.20535221 |
| 22 | positive regulation of vesicle fusion (GO:0031340) | 3.19515186 |
| 23 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.18444246 |
| 24 | cellular potassium ion homeostasis (GO:0030007) | 3.10285152 |
| 25 | erythrocyte development (GO:0048821) | 3.09895251 |
| 26 | beta-amyloid metabolic process (GO:0050435) | 3.06248909 |
| 27 | glycosphingolipid catabolic process (GO:0046479) | 2.97085426 |
| 28 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.93180002 |
| 29 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.92251038 |
| 30 | locomotory exploration behavior (GO:0035641) | 2.92133120 |
| 31 | regulation of vesicle fusion (GO:0031338) | 2.89583812 |
| 32 | vocalization behavior (GO:0071625) | 2.88878788 |
| 33 | neuronal action potential propagation (GO:0019227) | 2.86096492 |
| 34 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.85916302 |
| 35 | postsynaptic membrane organization (GO:0001941) | 2.85751947 |
| 36 | oligosaccharide catabolic process (GO:0009313) | 2.85659175 |
| 37 | membrane invagination (GO:0010324) | 2.82219789 |
| 38 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.81910359 |
| 39 | * positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.81058781 |
| 40 | clathrin coat assembly (GO:0048268) | 2.78794255 |
| 41 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.78776904 |
| 42 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.78776904 |
| 43 | vesicle docking involved in exocytosis (GO:0006904) | 2.78615522 |
| 44 | regulation of synaptic vesicle transport (GO:1902803) | 2.78253187 |
| 45 | tricarboxylic acid cycle (GO:0006099) | 2.71693071 |
| 46 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.71134131 |
| 47 | regulation of platelet aggregation (GO:0090330) | 2.70284698 |
| 48 | neurotransmitter secretion (GO:0007269) | 2.69497567 |
| 49 | adenosine receptor signaling pathway (GO:0001973) | 2.69316500 |
| 50 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.66758985 |
| 51 | * mitochondrial calcium ion transport (GO:0006851) | 2.66612702 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.65220360 |
| 53 | granulocyte differentiation (GO:0030851) | 2.63754105 |
| 54 | blood coagulation, intrinsic pathway (GO:0007597) | 2.63360723 |
| 55 | negative regulation of bone mineralization (GO:0030502) | 2.62699958 |
| 56 | long-term synaptic potentiation (GO:0060291) | 2.61602453 |
| 57 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.61149875 |
| 58 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.60996404 |
| 59 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.59839539 |
| 60 | neutrophil activation involved in immune response (GO:0002283) | 2.59093273 |
| 61 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.57885044 |
| 62 | glycolipid catabolic process (GO:0019377) | 2.57240852 |
| 63 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.56900999 |
| 64 | platelet degranulation (GO:0002576) | 2.56569233 |
| 65 | phagosome maturation (GO:0090382) | 2.55549974 |
| 66 | gamma-aminobutyric acid transport (GO:0015812) | 2.52686195 |
| 67 | * mitochondrial calcium ion homeostasis (GO:0051560) | 2.52630787 |
| 68 | regulation of oxidative phosphorylation (GO:0002082) | 2.50028391 |
| 69 | response to auditory stimulus (GO:0010996) | 2.48230380 |
| 70 | neurotransmitter catabolic process (GO:0042135) | 2.47842120 |
| 71 | vesicle docking (GO:0048278) | 2.47389027 |
| 72 | substantia nigra development (GO:0021762) | 2.47251509 |
| 73 | succinate metabolic process (GO:0006105) | 2.47139913 |
| 74 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.46905706 |
| 75 | virion attachment to host cell (GO:0019062) | 2.42185372 |
| 76 | adhesion of symbiont to host cell (GO:0044650) | 2.42185372 |
| 77 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.42122767 |
| 78 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.40345962 |
| 79 | ceramide catabolic process (GO:0046514) | 2.40078314 |
| 80 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.38823318 |
| 81 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.37818255 |
| 82 | negative regulation of biomineral tissue development (GO:0070168) | 2.37248434 |
| 83 | regulation of protein localization to cell surface (GO:2000008) | 2.36566904 |
| 84 | regulation of early endosome to late endosome transport (GO:2000641) | 2.36337376 |
| 85 | sodium ion export (GO:0071436) | 2.35613171 |
| 86 | regulation of metalloenzyme activity (GO:0048552) | 2.35346765 |
| 87 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.34437505 |
| 88 | response to methylmercury (GO:0051597) | 2.34176599 |
| 89 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.34096060 |
| 90 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.33611886 |
| 91 | regulation of protein targeting to membrane (GO:0090313) | 2.33561552 |
| 92 | negative regulation of dendrite development (GO:2000171) | 2.33138507 |
| 93 | protein targeting to plasma membrane (GO:0072661) | 2.32781294 |
| 94 | regulation of vacuole organization (GO:0044088) | 2.32482526 |
| 95 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.31235522 |
| 96 | macroautophagy (GO:0016236) | 2.30940488 |
| 97 | iron ion transport (GO:0006826) | 2.30866886 |
| 98 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.28822066 |
| 99 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.28643260 |
| 100 | valine metabolic process (GO:0006573) | 2.28425348 |
| 101 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.28295614 |
| 102 | peptidyl-cysteine modification (GO:0018198) | 2.28012081 |
| 103 | COPI coating of Golgi vesicle (GO:0048205) | 2.27310678 |
| 104 | Golgi transport vesicle coating (GO:0048200) | 2.27310678 |
| 105 | transferrin transport (GO:0033572) | 2.27088319 |
| 106 | innervation (GO:0060384) | 2.26591000 |
| 107 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.26379927 |
| 108 | positive regulation of glycolytic process (GO:0045821) | 2.25876922 |
| 109 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.25835706 |
| 110 | exploration behavior (GO:0035640) | 2.24386076 |
| 111 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.24313661 |
| 112 | glycine transport (GO:0015816) | 2.23161737 |
| 113 | nuclear envelope reassembly (GO:0031468) | 2.21967215 |
| 114 | mitotic nuclear envelope reassembly (GO:0007084) | 2.21967215 |
| 115 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.21870058 |
| 116 | relaxation of smooth muscle (GO:0044557) | 2.21718563 |
| 117 | alpha-linolenic acid metabolic process (GO:0036109) | 2.20809679 |
| 118 | membrane depolarization during action potential (GO:0086010) | 2.19894296 |
| 119 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.19735004 |
| 120 | positive regulation of synapse maturation (GO:0090129) | 2.19716477 |
| 121 | platelet formation (GO:0030220) | 2.18229367 |
| 122 | peroxisome fission (GO:0016559) | 2.18222268 |
| 123 | positive regulation of neurotransmitter transport (GO:0051590) | 2.17977355 |
| 124 | activation of protein kinase A activity (GO:0034199) | 2.17924592 |
| 125 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.17641701 |
| 126 | plasma membrane repair (GO:0001778) | 2.17490443 |
| 127 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.17278584 |
| 128 | oxaloacetate metabolic process (GO:0006107) | 2.17256120 |
| 129 | negative regulation of heart rate (GO:0010459) | 2.17135235 |
| 130 | glomerular epithelial cell development (GO:0072310) | 2.16512713 |
| 131 | glomerular visceral epithelial cell development (GO:0072015) | 2.16444107 |
| 132 | ferric iron transport (GO:0015682) | 2.15475427 |
| 133 | trivalent inorganic cation transport (GO:0072512) | 2.15475427 |
| 134 | regulation of neurotransmitter uptake (GO:0051580) | 2.15055694 |
| 135 | actin filament depolymerization (GO:0030042) | 2.14587177 |
| 136 | adhesion of symbiont to host (GO:0044406) | 2.13011921 |
| 137 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.12912844 |
| 138 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.12550163 |
| 139 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.12320212 |
| 140 | response to gravity (GO:0009629) | 2.11616839 |
| 141 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.11375993 |
| 142 | membrane hyperpolarization (GO:0060081) | 2.11328859 |
| 143 | prepulse inhibition (GO:0060134) | 2.10047247 |
| 144 | regulation of neurotransmitter transport (GO:0051588) | 2.09781909 |
| 145 | negative regulation of cation channel activity (GO:2001258) | 2.09581674 |
| 146 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.09271529 |
| 147 | regulation of synaptic plasticity (GO:0048167) | 2.08504253 |
| 148 | regulation of neurotransmitter secretion (GO:0046928) | 2.07790056 |
| 149 | striatum development (GO:0021756) | 2.07726117 |
| 150 | positive regulation of synaptic transmission (GO:0050806) | 2.05826039 |
| 151 | neuromuscular process controlling balance (GO:0050885) | 2.05563087 |
| 152 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.05015399 |
| 153 | synaptic vesicle endocytosis (GO:0048488) | 2.04886876 |
| 154 | neurotransmitter transport (GO:0006836) | 2.03474086 |
| 155 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.02793540 |
| 156 | proline transport (GO:0015824) | 2.02348898 |
| 157 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.01607788 |
| 158 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.01607788 |
| 159 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.01406890 |
| 160 | potassium ion homeostasis (GO:0055075) | 2.00919955 |
| 161 | fatty acid elongation (GO:0030497) | 2.00889119 |
| 162 | behavioral response to cocaine (GO:0048148) | 2.00755624 |
| 163 | neuromuscular synaptic transmission (GO:0007274) | 2.00437974 |
| 164 | neuron cell-cell adhesion (GO:0007158) | 1.99945613 |
| 165 | dopamine receptor signaling pathway (GO:0007212) | 1.98874898 |
| 166 | dendrite morphogenesis (GO:0048813) | 1.97686746 |
| 167 | neuron-neuron synaptic transmission (GO:0007270) | 1.97375102 |
| 168 | positive regulation of axon extension (GO:0045773) | 1.97335014 |
| 169 | auditory behavior (GO:0031223) | 1.96296346 |
| 170 | L-glutamate transport (GO:0015813) | 1.95932030 |
| 171 | regulation of beta-amyloid formation (GO:1902003) | 1.95718414 |
| 172 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 1.95413795 |
| 173 | angiotensin maturation (GO:0002003) | 1.94693872 |
| 174 | protein localization to synapse (GO:0035418) | 1.94232245 |
| 175 | acidic amino acid transport (GO:0015800) | 1.91830709 |
| 176 | chemosensory behavior (GO:0007635) | 1.91774810 |
| 177 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 1.91169649 |
| 178 | regulation of neurotransmitter levels (GO:0001505) | 1.90731645 |
| 179 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 1.89935742 |
| 180 | axon extension involved in axon guidance (GO:0048846) | 1.89935742 |
| 181 | positive regulation of p38MAPK cascade (GO:1900745) | 1.89888466 |
| 182 | negative regulation of sodium ion transport (GO:0010766) | 1.89086301 |
| 183 | axonal fasciculation (GO:0007413) | 1.88860836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.19588088 |
| 2 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.04129079 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.79915642 |
| 4 | GATA1_19941826_ChIP-Seq_K562_Human | 2.69707865 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.47925365 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.46093605 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.45240095 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.40083773 |
| 9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.22576027 |
| 10 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.15064849 |
| 11 | EOMES_21245162_ChIP-Seq_HESCs_Human | 2.12778034 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09186459 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.08656213 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.07001889 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.07001889 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.06556107 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.05078678 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.04678750 |
| 19 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.04585842 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.03901589 |
| 21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.03001016 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.01212367 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.96735360 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.95987007 |
| 25 | GATA2_19941826_ChIP-Seq_K562_Human | 1.95303686 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.92181006 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91783558 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.90651453 |
| 29 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.88880179 |
| 30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83236902 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81546779 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.81539491 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79862094 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.79375019 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75284789 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70027719 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.68901330 |
| 38 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.68054657 |
| 39 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.67424911 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.66467381 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.65447693 |
| 42 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.61257349 |
| 43 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.60451552 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58947415 |
| 45 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.57910603 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57603043 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.56126875 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.55739644 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55528230 |
| 50 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.52873967 |
| 51 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.51662560 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50692232 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49444986 |
| 54 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.48997388 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.43804365 |
| 56 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.41834506 |
| 57 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.38189169 |
| 58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37963711 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37854856 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.36908488 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36873943 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34011497 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34011497 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33958263 |
| 65 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.32958019 |
| 66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32456761 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30026850 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29252222 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25866419 |
| 70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25784424 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25120689 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25004571 |
| 73 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24809539 |
| 74 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.24754623 |
| 75 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.24432237 |
| 76 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.23586398 |
| 77 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.23204494 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22565136 |
| 79 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.22552537 |
| 80 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21659714 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21538801 |
| 82 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.21478886 |
| 83 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.19291233 |
| 84 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18358560 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17167932 |
| 86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16688629 |
| 87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15568332 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15005180 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14632890 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11823234 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11727241 |
| 92 | CJUN_26792858_Chip-Seq_BT549_Human | 1.11191811 |
| 93 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10403685 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10271736 |
| 95 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09387922 |
| 96 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06748443 |
| 97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06585960 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06517715 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05469890 |
| 100 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04937524 |
| 101 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04001531 |
| 102 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03299478 |
| 103 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02906457 |
| 104 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02596039 |
| 105 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02417267 |
| 106 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.02326637 |
| 107 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.02087826 |
| 108 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01349351 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01043661 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98044986 |
| 111 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97468971 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97405649 |
| 113 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96226167 |
| 114 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95740837 |
| 115 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95151498 |
| 116 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.95074737 |
| 117 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93606707 |
| 118 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93183254 |
| 119 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92633002 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92621366 |
| 121 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92607553 |
| 122 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92536675 |
| 123 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92477886 |
| 124 | AR_25329375_ChIP-Seq_VCAP_Human | 0.92292673 |
| 125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91796047 |
| 126 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90864608 |
| 127 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90470135 |
| 128 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89927897 |
| 129 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.88907837 |
| 130 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.88824096 |
| 131 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.88257794 |
| 132 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86667239 |
| 133 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.86437270 |
| 134 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84553544 |
| 135 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84194186 |
| 136 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.83615685 |
| 137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82231363 |
| 138 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.82123473 |
| 139 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.81995548 |
| 140 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.81984206 |
| 141 | AR_19668381_ChIP-Seq_PC3_Human | 0.81816953 |
| 142 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81814057 |
| 143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81673434 |
| 144 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.81073772 |
| 145 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80873770 |
| 146 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.80546858 |
| 147 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.80429467 |
| 148 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80297377 |
| 149 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.79825768 |
| 150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79620644 |
| 151 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79457955 |
| 152 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.78810296 |
| 153 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78743603 |
| 154 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.78300728 |
| 155 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.78277592 |
| 156 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.77916010 |
| 157 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.77506668 |
| 158 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75305808 |
| 159 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74033730 |
| 160 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.73977143 |
| 161 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73796834 |
| 162 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73662014 |
| 163 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.72698853 |
| 164 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.72649866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.04606479 |
| 2 | MP0005464_abnormal_platelet_physiology | 3.71095679 |
| 3 | MP0004858_abnormal_nervous_system | 3.14178966 |
| 4 | MP0002132_abnormal_respiratory_system | 3.11291863 |
| 5 | MP0004270_analgesia | 2.82285144 |
| 6 | MP0002736_abnormal_nociception_after | 2.81883046 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.74478691 |
| 8 | MP0003329_amyloid_beta_deposits | 2.57047282 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 2.49632288 |
| 10 | MP0003183_abnormal_peptide_metabolism | 2.47731430 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.44793162 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.39367723 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.34276182 |
| 14 | MP0002822_catalepsy | 2.33161733 |
| 15 | MP0004147_increased_porphyrin_level | 2.27927130 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.26636590 |
| 17 | MP0003880_abnormal_central_pattern | 2.16501558 |
| 18 | MP0008004_abnormal_stomach_pH | 2.05789742 |
| 19 | MP0002063_abnormal_learning/memory/cond | 2.00832701 |
| 20 | MP0002064_seizures | 1.99658671 |
| 21 | MP0009745_abnormal_behavioral_response | 1.97946024 |
| 22 | MP0002735_abnormal_chemical_nociception | 1.91142506 |
| 23 | MP0005623_abnormal_meninges_morphology | 1.86984889 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.84245958 |
| 25 | MP0005365_abnormal_bile_salt | 1.83479364 |
| 26 | MP0005083_abnormal_biliary_tract | 1.83443861 |
| 27 | MP0000751_myopathy | 1.82389512 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.79201783 |
| 29 | MP0001661_extended_life_span | 1.78995296 |
| 30 | MP0001970_abnormal_pain_threshold | 1.76847065 |
| 31 | MP0005275_abnormal_skin_tensile | 1.75954623 |
| 32 | MP0009046_muscle_twitch | 1.75755300 |
| 33 | MP0000749_muscle_degeneration | 1.74966534 |
| 34 | MP0003186_abnormal_redox_activity | 1.71185120 |
| 35 | MP0000604_amyloidosis | 1.70484202 |
| 36 | MP0001958_emphysema | 1.69871829 |
| 37 | MP0002090_abnormal_vision | 1.65049255 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.64086291 |
| 39 | MP0003879_abnormal_hair_cell | 1.63874672 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.60829714 |
| 41 | MP0005503_abnormal_tendon_morphology | 1.59756872 |
| 42 | MP0001984_abnormal_olfaction | 1.57773167 |
| 43 | MP0000343_altered_response_to | 1.57076800 |
| 44 | MP0004036_abnormal_muscle_relaxation | 1.55999020 |
| 45 | MP0002272_abnormal_nervous_system | 1.55216415 |
| 46 | MP0005451_abnormal_body_composition | 1.54838024 |
| 47 | MP0000013_abnormal_adipose_tissue | 1.53005524 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52950471 |
| 49 | MP0003075_altered_response_to | 1.51889036 |
| 50 | MP0002295_abnormal_pulmonary_circulatio | 1.50978296 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.49423586 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.49423586 |
| 53 | MP0004130_abnormal_muscle_cell | 1.46183188 |
| 54 | MP0002572_abnormal_emotion/affect_behav | 1.45034588 |
| 55 | MP0002139_abnormal_hepatobiliary_system | 1.44911783 |
| 56 | MP0008569_lethality_at_weaning | 1.39174672 |
| 57 | MP0002089_abnormal_postnatal_growth/wei | 1.38385379 |
| 58 | MP0001542_abnormal_bone_strength | 1.35169752 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.30142105 |
| 60 | MP0001440_abnormal_grooming_behavior | 1.29460114 |
| 61 | MP0003633_abnormal_nervous_system | 1.29455678 |
| 62 | MP0005332_abnormal_amino_acid | 1.28554239 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.26331805 |
| 64 | MP0001502_abnormal_circadian_rhythm | 1.24477668 |
| 65 | MP0003091_abnormal_cell_migration | 1.23697680 |
| 66 | MP0001299_abnormal_eye_distance/ | 1.22204189 |
| 67 | MP0001346_abnormal_lacrimal_gland | 1.21552322 |
| 68 | MP0005636_abnormal_mineral_homeostasis | 1.19712479 |
| 69 | MP0003045_fibrosis | 1.19312091 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 1.18802060 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 1.18688669 |
| 72 | MP0004084_abnormal_cardiac_muscle | 1.18078142 |
| 73 | MP0001486_abnormal_startle_reflex | 1.17348568 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.16283246 |
| 75 | MP0002269_muscular_atrophy | 1.16015104 |
| 76 | MP0010329_abnormal_lipoprotein_level | 1.13326545 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 1.12340029 |
| 78 | MP0003122_maternal_imprinting | 1.10933404 |
| 79 | MP0002067_abnormal_sensory_capabilities | 1.10820133 |
| 80 | MP0009384_cardiac_valve_regurgitation | 1.09997616 |
| 81 | MP0004811_abnormal_neuron_physiology | 1.09942206 |
| 82 | MP0005646_abnormal_pituitary_gland | 1.08550792 |
| 83 | MP0000358_abnormal_cell_content/ | 1.08509819 |
| 84 | MP0004233_abnormal_muscle_weight | 1.07297336 |
| 85 | MP0008775_abnormal_heart_ventricle | 1.05644429 |
| 86 | MP0004134_abnormal_chest_morphology | 1.04702388 |
| 87 | MP0010386_abnormal_urinary_bladder | 1.03219711 |
| 88 | MP0002971_abnormal_brown_adipose | 1.01962682 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 1.01830230 |
| 90 | MP0003172_abnormal_lysosome_physiology | 1.01189085 |
| 91 | MP0003566_abnormal_cell_adhesion | 1.00388514 |
| 92 | MP0009840_abnormal_foam_cell | 0.98726807 |
| 93 | MP0002108_abnormal_muscle_morphology | 0.97696897 |
| 94 | MP0002184_abnormal_innervation | 0.97465698 |
| 95 | MP0002653_abnormal_ependyma_morphology | 0.97237405 |
| 96 | MP0003632_abnormal_nervous_system | 0.96870620 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 0.95912002 |
| 98 | MP0003631_nervous_system_phenotype | 0.95909064 |
| 99 | MP0000955_abnormal_spinal_cord | 0.95499107 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.94859225 |
| 101 | MP0003634_abnormal_glial_cell | 0.94767420 |
| 102 | MP0003828_pulmonary_edema | 0.94743190 |
| 103 | MP0000759_abnormal_skeletal_muscle | 0.94608278 |
| 104 | MP0001533_abnormal_skeleton_physiology | 0.94047321 |
| 105 | MP0002102_abnormal_ear_morphology | 0.94000921 |
| 106 | MP0000920_abnormal_myelination | 0.93194775 |
| 107 | MP0002972_abnormal_cardiac_muscle | 0.92923557 |
| 108 | MP0001177_atelectasis | 0.92134549 |
| 109 | MP0002118_abnormal_lipid_homeostasis | 0.91855446 |
| 110 | MP0008260_abnormal_autophagy | 0.91600296 |
| 111 | MP0003690_abnormal_glial_cell | 0.91393419 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.90947086 |
| 113 | MP0004885_abnormal_endolymph | 0.90497642 |
| 114 | MP0001664_abnormal_digestion | 0.90122575 |
| 115 | MP0004883_abnormal_blood_vessel | 0.89838979 |
| 116 | MP0003646_muscle_fatigue | 0.89692371 |
| 117 | MP0006054_spinal_hemorrhage | 0.89196874 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.88895304 |
| 119 | MP0000747_muscle_weakness | 0.88185156 |
| 120 | MP0000681_abnormal_thyroid_gland | 0.86601522 |
| 121 | MP0002796_impaired_skin_barrier | 0.84364905 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.83577692 |
| 123 | MP0002882_abnormal_neuron_morphology | 0.82691594 |
| 124 | MP0002066_abnormal_motor_capabilities/c | 0.82634151 |
| 125 | MP0003950_abnormal_plasma_membrane | 0.82439867 |
| 126 | MP0010771_integument_phenotype | 0.82306993 |
| 127 | MP0001666_abnormal_nutrient_absorption | 0.81892737 |
| 128 | MP0005164_abnormal_response_to | 0.81335232 |
| 129 | MP0003283_abnormal_digestive_organ | 0.80745768 |
| 130 | MP0006276_abnormal_autonomic_nervous | 0.78764163 |
| 131 | MP0001529_abnormal_vocalization | 0.77954967 |
| 132 | MP0003959_abnormal_lean_body | 0.77318891 |
| 133 | MP0008872_abnormal_physiological_respon | 0.76748369 |
| 134 | MP0003191_abnormal_cellular_cholesterol | 0.75696403 |
| 135 | MP0004947_skin_inflammation | 0.75542604 |
| 136 | MP0002229_neurodegeneration | 0.75405673 |
| 137 | MP0005595_abnormal_vascular_smooth | 0.75013771 |
| 138 | MP0002557_abnormal_social/conspecific_i | 0.74935977 |
| 139 | MP0003300_gastrointestinal_ulcer | 0.74493931 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.74297869 |
| 141 | MP0008874_decreased_physiological_sensi | 0.73287064 |
| 142 | MP0001188_hyperpigmentation | 0.72706523 |
| 143 | MP0002078_abnormal_glucose_homeostasis | 0.71295051 |
| 144 | MP0002998_abnormal_bone_remodeling | 0.70807536 |
| 145 | MP0005410_abnormal_fertilization | 0.70700305 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.69693240 |
| 147 | MP0005620_abnormal_muscle_contractility | 0.67306228 |
| 148 | MP0005166_decreased_susceptibility_to | 0.66051958 |
| 149 | MP0002876_abnormal_thyroid_physiology | 0.65933641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 5.68346821 |
| 2 | Prolonged bleeding time (HP:0003010) | 4.84892990 |
| 3 | Type 1 muscle fiber predominance (HP:0003803) | 4.03001257 |
| 4 | Abnormal platelet function (HP:0011869) | 4.00861822 |
| 5 | Impaired platelet aggregation (HP:0003540) | 4.00861822 |
| 6 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.76119685 |
| 7 | Acanthocytosis (HP:0001927) | 3.61479100 |
| 8 | Ileus (HP:0002595) | 3.54762325 |
| 9 | Purpura (HP:0000979) | 3.54560660 |
| 10 | Menorrhagia (HP:0000132) | 3.53722513 |
| 11 | Increased mean platelet volume (HP:0011877) | 3.52268293 |
| 12 | Muscle fiber inclusion bodies (HP:0100299) | 3.51605733 |
| 13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.46345014 |
| 14 | Nemaline bodies (HP:0003798) | 3.44487104 |
| 15 | Myokymia (HP:0002411) | 3.43293677 |
| 16 | Abnormal platelet volume (HP:0011876) | 3.28177510 |
| 17 | Poikilocytosis (HP:0004447) | 3.27840564 |
| 18 | Fetal akinesia sequence (HP:0001989) | 3.26851764 |
| 19 | Reticulocytosis (HP:0001923) | 3.20804876 |
| 20 | Ankle clonus (HP:0011448) | 3.09391147 |
| 21 | Polycythemia (HP:0001901) | 3.07169986 |
| 22 | Distal arthrogryposis (HP:0005684) | 3.03181568 |
| 23 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.00121530 |
| 24 | Focal motor seizures (HP:0011153) | 2.90457162 |
| 25 | Hyperthyroidism (HP:0000836) | 2.89881479 |
| 26 | Gingival bleeding (HP:0000225) | 2.85762080 |
| 27 | Epistaxis (HP:0000421) | 2.79244865 |
| 28 | Short middle phalanx of the 5th finger (HP:0004220) | 2.74560523 |
| 29 | Neonatal short-limb short stature (HP:0008921) | 2.71396108 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 2.68989079 |
| 31 | Cholecystitis (HP:0001082) | 2.61107546 |
| 32 | Abnormal gallbladder physiology (HP:0012438) | 2.61107546 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 2.60150350 |
| 34 | Supranuclear gaze palsy (HP:0000605) | 2.59842792 |
| 35 | Akinesia (HP:0002304) | 2.58910843 |
| 36 | Epileptic encephalopathy (HP:0200134) | 2.58890876 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 2.58888382 |
| 38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.58888382 |
| 39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.58888382 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.58877337 |
| 41 | Cupped ribs (HP:0000887) | 2.56863898 |
| 42 | Exercise-induced myalgia (HP:0003738) | 2.56407452 |
| 43 | Focal seizures (HP:0007359) | 2.49371835 |
| 44 | Myopathic facies (HP:0002058) | 2.48292459 |
| 45 | Atonic seizures (HP:0010819) | 2.48259887 |
| 46 | Epiphyseal dysplasia (HP:0002656) | 2.46442786 |
| 47 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.44873637 |
| 48 | Premature rupture of membranes (HP:0001788) | 2.43237074 |
| 49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.40667043 |
| 50 | Protrusio acetabuli (HP:0003179) | 2.35758288 |
| 51 | Complete atrioventricular canal defect (HP:0001674) | 2.34690132 |
| 52 | Ulnar deviation of the wrist (HP:0003049) | 2.31663854 |
| 53 | Torticollis (HP:0000473) | 2.31615633 |
| 54 | Xanthomatosis (HP:0000991) | 2.29661881 |
| 55 | Absent phalangeal crease (HP:0006109) | 2.29405075 |
| 56 | Hydroxyprolinuria (HP:0003080) | 2.25774171 |
| 57 | Abnormality of proline metabolism (HP:0010907) | 2.25774171 |
| 58 | Scapular winging (HP:0003691) | 2.24101617 |
| 59 | Irregular epiphyses (HP:0010582) | 2.23670326 |
| 60 | Microglossia (HP:0000171) | 2.22331084 |
| 61 | Broad metatarsal (HP:0001783) | 2.22040091 |
| 62 | Vertebral compression fractures (HP:0002953) | 2.21197909 |
| 63 | Abnormality of glycolysis (HP:0004366) | 2.19878458 |
| 64 | Delusions (HP:0000746) | 2.18716423 |
| 65 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.18677505 |
| 66 | Mitral stenosis (HP:0001718) | 2.18456014 |
| 67 | Central scotoma (HP:0000603) | 2.17493847 |
| 68 | Increased serum pyruvate (HP:0003542) | 2.16793548 |
| 69 | Hypoventilation (HP:0002791) | 2.16543320 |
| 70 | Mutism (HP:0002300) | 2.16263940 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.15416267 |
| 72 | Hypoplastic iliac wings (HP:0002866) | 2.15343904 |
| 73 | Pheochromocytoma (HP:0002666) | 2.15004249 |
| 74 | Round ear (HP:0100830) | 2.13446696 |
| 75 | Congenital stationary night blindness (HP:0007642) | 2.12963065 |
| 76 | Aplasia involving bones of the extremities (HP:0009825) | 2.11208554 |
| 77 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.11208554 |
| 78 | Aplasia of the phalanges of the hand (HP:0009802) | 2.11208554 |
| 79 | Hypokinesia (HP:0002375) | 2.10990935 |
| 80 | Lumbar hyperlordosis (HP:0002938) | 2.10566929 |
| 81 | Lower limb amyotrophy (HP:0007210) | 2.09885534 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 2.09873718 |
| 83 | Abnormality of dental color (HP:0011073) | 2.08841978 |
| 84 | Calcaneovalgus deformity (HP:0001848) | 2.08601616 |
| 85 | Upper limb muscle weakness (HP:0003484) | 2.08320285 |
| 86 | Cholelithiasis (HP:0001081) | 2.06769931 |
| 87 | Visual hallucinations (HP:0002367) | 2.05546249 |
| 88 | Abnormality of magnesium homeostasis (HP:0004921) | 2.03914444 |
| 89 | Hyporeflexia of lower limbs (HP:0002600) | 2.00951358 |
| 90 | Febrile seizures (HP:0002373) | 1.99856245 |
| 91 | Gowers sign (HP:0003391) | 1.97836249 |
| 92 | Ovoid vertebral bodies (HP:0003300) | 1.97701432 |
| 93 | Atrioventricular canal defect (HP:0006695) | 1.97008030 |
| 94 | Acute necrotizing encephalopathy (HP:0006965) | 1.96427630 |
| 95 | Abnormal gallbladder morphology (HP:0012437) | 1.96138792 |
| 96 | Dysostosis multiplex (HP:0000943) | 1.95363105 |
| 97 | Bruising susceptibility (HP:0000978) | 1.95200058 |
| 98 | Hip contracture (HP:0003273) | 1.94996632 |
| 99 | Abnormality of the common coagulation pathway (HP:0010990) | 1.94829428 |
| 100 | Hypomagnesemia (HP:0002917) | 1.94643824 |
| 101 | Action tremor (HP:0002345) | 1.94509590 |
| 102 | Slender build (HP:0001533) | 1.93494571 |
| 103 | Vascular tortuosity (HP:0004948) | 1.93442576 |
| 104 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.93441465 |
| 105 | Distal lower limb amyotrophy (HP:0008944) | 1.93144340 |
| 106 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.92384818 |
| 107 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.92384818 |
| 108 | Craniofacial dystonia (HP:0012179) | 1.90301590 |
| 109 | Osteoarthritis (HP:0002758) | 1.88978917 |
| 110 | Deformed tarsal bones (HP:0008119) | 1.88738164 |
| 111 | Aortic aneurysm (HP:0004942) | 1.88708642 |
| 112 | Hepatic necrosis (HP:0002605) | 1.88617164 |
| 113 | Focal dystonia (HP:0004373) | 1.88048399 |
| 114 | Neuroendocrine neoplasm (HP:0100634) | 1.87328957 |
| 115 | Absence seizures (HP:0002121) | 1.87215029 |
| 116 | Frequent falls (HP:0002359) | 1.86488512 |
| 117 | Upper limb amyotrophy (HP:0009129) | 1.85830441 |
| 118 | Distal upper limb amyotrophy (HP:0007149) | 1.85830441 |
| 119 | Difficulty running (HP:0009046) | 1.85602468 |
| 120 | Dilatation of the ascending aorta (HP:0005111) | 1.85522639 |
| 121 | Brushfield spots (HP:0001088) | 1.85356242 |
| 122 | Lower limb muscle weakness (HP:0007340) | 1.85247174 |
| 123 | Muscle stiffness (HP:0003552) | 1.84400493 |
| 124 | Weak cry (HP:0001612) | 1.83749051 |
| 125 | Cervical subluxation (HP:0003308) | 1.83149234 |
| 126 | Flat acetabular roof (HP:0003180) | 1.83124857 |
| 127 | Pterygium (HP:0001059) | 1.82774971 |
| 128 | Abnormality of macular pigmentation (HP:0008002) | 1.82564432 |
| 129 | Skin nodule (HP:0200036) | 1.81711749 |
| 130 | Acute encephalopathy (HP:0006846) | 1.80666668 |
| 131 | Mild short stature (HP:0003502) | 1.79486707 |
| 132 | Distal lower limb muscle weakness (HP:0009053) | 1.78988533 |
| 133 | Abnormal finger flexion creases (HP:0006143) | 1.78934892 |
| 134 | Hypercortisolism (HP:0001578) | 1.78655401 |
| 135 | Vitreoretinal degeneration (HP:0000655) | 1.78034837 |
| 136 | Ventricular fibrillation (HP:0001663) | 1.77174237 |
| 137 | Abnormality of the corticospinal tract (HP:0002492) | 1.77064226 |
| 138 | Peritonitis (HP:0002586) | 1.76253989 |
| 139 | Arterial tortuosity (HP:0005116) | 1.75539728 |
| 140 | Ankle contracture (HP:0006466) | 1.75030253 |
| 141 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.74333245 |
| 142 | Popliteal pterygium (HP:0009756) | 1.74113715 |
| 143 | Abnormal eating behavior (HP:0100738) | 1.74039607 |
| 144 | Megalencephaly (HP:0001355) | 1.73749423 |
| 145 | Flat capital femoral epiphysis (HP:0003370) | 1.72916831 |
| 146 | Hammertoe (HP:0001765) | 1.72335602 |
| 147 | Abnormality of the acetabulum (HP:0003170) | 1.72167774 |
| 148 | Hemiparesis (HP:0001269) | 1.71622522 |
| 149 | Urinary urgency (HP:0000012) | 1.70630115 |
| 150 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.70511362 |
| 151 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.70511362 |
| 152 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.70511362 |
| 153 | Increased CSF lactate (HP:0002490) | 1.70434987 |
| 154 | Shallow orbits (HP:0000586) | 1.70273699 |
| 155 | Spinal canal stenosis (HP:0003416) | 1.69376854 |
| 156 | Ketoacidosis (HP:0001993) | 1.68901154 |
| 157 | Dialeptic seizures (HP:0011146) | 1.68617703 |
| 158 | Progressive macrocephaly (HP:0004481) | 1.68563040 |
| 159 | Abnormality of the calcaneus (HP:0008364) | 1.68492930 |
| 160 | Diminished movement (HP:0002374) | 1.67518421 |
| 161 | Depression (HP:0000716) | 1.67400155 |
| 162 | Hyperalaninemia (HP:0003348) | 1.66828934 |
| 163 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.66828934 |
| 164 | Abnormality of alanine metabolism (HP:0010916) | 1.66828934 |
| 165 | Cerebral inclusion bodies (HP:0100314) | 1.66355624 |
| 166 | Clonus (HP:0002169) | 1.65992151 |
| 167 | EMG: myopathic abnormalities (HP:0003458) | 1.65832396 |
| 168 | Limited hip movement (HP:0008800) | 1.65804986 |
| 169 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.65197939 |
| 170 | Delayed gross motor development (HP:0002194) | 1.64651627 |
| 171 | Progressive microcephaly (HP:0000253) | 1.64451641 |
| 172 | Hepatocellular necrosis (HP:0001404) | 1.64230545 |
| 173 | Increased cerebral lipofuscin (HP:0011813) | 1.63747514 |
| 174 | Spinal rigidity (HP:0003306) | 1.63266102 |
| 175 | Right ventricular cardiomyopathy (HP:0011663) | 1.62687403 |
| 176 | Abnormality of the calf musculature (HP:0001430) | 1.61364072 |
| 177 | Generalized tonic-clonic seizures (HP:0002069) | 1.60668659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 3.41775880 |
| 2 | PDK2 | 2.31464810 |
| 3 | MYLK | 2.30974215 |
| 4 | DDR2 | 2.30357167 |
| 5 | NTRK3 | 2.29044108 |
| 6 | MAP3K12 | 2.25626883 |
| 7 | EPHA4 | 2.16126010 |
| 8 | LIMK1 | 2.06493454 |
| 9 | NTRK1 | 2.02584797 |
| 10 | MAP3K9 | 2.01460334 |
| 11 | DAPK2 | 1.98374048 |
| 12 | MAPK13 | 1.93177060 |
| 13 | PIM2 | 1.89832876 |
| 14 | TRIB3 | 1.80350860 |
| 15 | LMTK2 | 1.80185152 |
| 16 | MARK1 | 1.79894280 |
| 17 | MINK1 | 1.78798855 |
| 18 | PNCK | 1.75995888 |
| 19 | KSR2 | 1.74133852 |
| 20 | STK10 | 1.71252327 |
| 21 | CAMKK2 | 1.66826607 |
| 22 | ARAF | 1.64975817 |
| 23 | EPHB1 | 1.63536180 |
| 24 | PAK6 | 1.63319071 |
| 25 | MAP4K2 | 1.61319760 |
| 26 | NTRK2 | 1.59012851 |
| 27 | WNK4 | 1.51893639 |
| 28 | CASK | 1.51771559 |
| 29 | MAP3K2 | 1.51203438 |
| 30 | CAMKK1 | 1.51200776 |
| 31 | MST1R | 1.42159379 |
| 32 | TAOK1 | 1.39633441 |
| 33 | SGK223 | 1.38363981 |
| 34 | SGK494 | 1.38363981 |
| 35 | SIK3 | 1.33002799 |
| 36 | MOS | 1.32812200 |
| 37 | FER | 1.32187200 |
| 38 | TAOK3 | 1.31838129 |
| 39 | RIPK1 | 1.30540771 |
| 40 | RIPK4 | 1.28436923 |
| 41 | MAP3K4 | 1.27671991 |
| 42 | CDK5 | 1.27438746 |
| 43 | MAP2K1 | 1.26543752 |
| 44 | TESK1 | 1.23356286 |
| 45 | SIK2 | 1.16398105 |
| 46 | ERN1 | 1.15955069 |
| 47 | CAMK2G | 1.13386510 |
| 48 | PRKD3 | 1.11710086 |
| 49 | CAMK1 | 1.07080381 |
| 50 | PIK3CG | 1.06748203 |
| 51 | KSR1 | 1.06545155 |
| 52 | RAF1 | 1.03558446 |
| 53 | TYRO3 | 1.02993292 |
| 54 | BRSK1 | 1.00171732 |
| 55 | EPHB2 | 0.99162004 |
| 56 | TRPM7 | 0.99110766 |
| 57 | PLK2 | 0.99022398 |
| 58 | PTK2B | 0.98341727 |
| 59 | CDK8 | 0.97769515 |
| 60 | ROCK2 | 0.97755887 |
| 61 | ERBB3 | 0.97436150 |
| 62 | MAP2K3 | 0.97209857 |
| 63 | RET | 0.96665470 |
| 64 | MAP2K7 | 0.94848634 |
| 65 | IRAK3 | 0.93361195 |
| 66 | FES | 0.92901523 |
| 67 | MAP3K1 | 0.92632472 |
| 68 | PKN1 | 0.91652331 |
| 69 | GRK5 | 0.91507213 |
| 70 | PRKG2 | 0.91389206 |
| 71 | SGK2 | 0.91369009 |
| 72 | ROCK1 | 0.89472848 |
| 73 | TTN | 0.88385179 |
| 74 | SGK3 | 0.87317355 |
| 75 | PHKG2 | 0.87108138 |
| 76 | PHKG1 | 0.87108138 |
| 77 | ABL2 | 0.84665421 |
| 78 | AKT3 | 0.83308023 |
| 79 | MAP3K13 | 0.83212206 |
| 80 | PTK2 | 0.82907740 |
| 81 | EPHA3 | 0.81954542 |
| 82 | PRPF4B | 0.81710941 |
| 83 | CDK18 | 0.81338991 |
| 84 | MAPKAPK5 | 0.80755483 |
| 85 | PRKCH | 0.78921700 |
| 86 | CDK14 | 0.77965504 |
| 87 | FGFR2 | 0.77857338 |
| 88 | OBSCN | 0.77265511 |
| 89 | ILK | 0.76901087 |
| 90 | OXSR1 | 0.76634482 |
| 91 | PRKD1 | 0.76522118 |
| 92 | DAPK1 | 0.76379691 |
| 93 | TRIM28 | 0.75265339 |
| 94 | FRK | 0.75053815 |
| 95 | PINK1 | 0.74669375 |
| 96 | CAMK2D | 0.73612230 |
| 97 | CAMK2B | 0.72965087 |
| 98 | CDK15 | 0.72723957 |
| 99 | PDGFRA | 0.71839899 |
| 100 | BMPR2 | 0.70520205 |
| 101 | PAK1 | 0.70055013 |
| 102 | PDPK1 | 0.69937883 |
| 103 | MAP2K6 | 0.69471924 |
| 104 | PDK1 | 0.69188654 |
| 105 | BMX | 0.68822816 |
| 106 | PRKCE | 0.68365892 |
| 107 | FGFR4 | 0.67987476 |
| 108 | CDK19 | 0.67701348 |
| 109 | MAP2K4 | 0.67631828 |
| 110 | MAP3K8 | 0.67064902 |
| 111 | TNK2 | 0.66228789 |
| 112 | PRKCZ | 0.65105456 |
| 113 | ADRBK1 | 0.59933620 |
| 114 | PRKCG | 0.59330764 |
| 115 | DAPK3 | 0.59145202 |
| 116 | BRAF | 0.58838405 |
| 117 | MET | 0.57990580 |
| 118 | MAP3K3 | 0.57163485 |
| 119 | LRRK2 | 0.56095552 |
| 120 | CDK11A | 0.55595506 |
| 121 | MST4 | 0.55293196 |
| 122 | NEK2 | 0.54978877 |
| 123 | MARK2 | 0.54156860 |
| 124 | FGR | 0.54108839 |
| 125 | PAK3 | 0.53580682 |
| 126 | JAK1 | 0.52282684 |
| 127 | PTK6 | 0.51628912 |
| 128 | PAK4 | 0.50451506 |
| 129 | BCR | 0.49819839 |
| 130 | RPS6KA2 | 0.49607390 |
| 131 | CAMK2A | 0.48662972 |
| 132 | CCNB1 | 0.48168316 |
| 133 | PRKACG | 0.47721721 |
| 134 | WNK1 | 0.46476695 |
| 135 | BCKDK | 0.46291737 |
| 136 | DMPK | 0.45892626 |
| 137 | GRK7 | 0.43819532 |
| 138 | DYRK2 | 0.41970210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.88213117 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.54218198 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.51331102 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.01996807 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.81901384 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.77796018 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69993745 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 1.69257864 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.64217088 |
| 10 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.63846756 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.63225903 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55347527 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 1.51340545 |
| 14 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.50722670 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.49306324 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.46065501 |
| 17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.45879873 |
| 18 | Nicotine addiction_Homo sapiens_hsa05033 | 1.45752116 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 1.39969825 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.39755391 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38591885 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.35168969 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33247209 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.30667760 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.30115032 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.29248043 |
| 27 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.27765726 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25147137 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25015707 |
| 30 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.21448278 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.21119281 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19716217 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.19346560 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16850701 |
| 35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.15103697 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.13460053 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12526583 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.12470114 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.11374649 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10891326 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.07662261 |
| 42 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.06441243 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.06375894 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.06029048 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05994083 |
| 46 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.05900655 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 1.05881943 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05026369 |
| 49 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.04821979 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04367490 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.04354994 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 1.00142956 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99954298 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.99068777 |
| 55 | Axon guidance_Homo sapiens_hsa04360 | 0.98129384 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96994137 |
| 57 | Long-term potentiation_Homo sapiens_hsa04720 | 0.96692406 |
| 58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.96571924 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95964593 |
| 60 | Long-term depression_Homo sapiens_hsa04730 | 0.95648685 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.93529157 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93065253 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.91597568 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.91317389 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91064192 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.90450944 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90263247 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.89619905 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86527245 |
| 70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86478719 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.86424081 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85518984 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85175336 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.84563245 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84115085 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81379314 |
| 77 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.81362415 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80362339 |
| 79 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80226467 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78980561 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78224877 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77218425 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.73507871 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.72933873 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72872840 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72796254 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72278737 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71637710 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70655345 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70164289 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.70082814 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.69702730 |
| 93 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.69646493 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68185787 |
| 95 | Taste transduction_Homo sapiens_hsa04742 | 0.67703330 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67633711 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67497797 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66267338 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65559515 |
| 100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65416265 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.65083428 |
| 102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64526333 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63877383 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63683257 |
| 105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62978891 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62333262 |
| 107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61578513 |
| 108 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.61402578 |
| 109 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.59235768 |
| 110 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58975853 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58748381 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57777598 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.55500767 |
| 114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55482467 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54989169 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54189308 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54075793 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53749145 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53010741 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52892797 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52734083 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50937757 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50677382 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50014362 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49592121 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.49304351 |
| 127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48928096 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46729066 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46629674 |
| 130 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46557075 |
| 131 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46545657 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46538277 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46051774 |
| 134 | Tuberculosis_Homo sapiens_hsa05152 | 0.45234558 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44833578 |
| 136 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44520606 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43367171 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42699282 |
| 139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42293094 |
| 140 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.41760348 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.41102706 |
| 142 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39135031 |

